Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you're already on bisoprolol for your heart and you're considering Mounjaro for weight management, the good news is that there is no known direct pharmacokinetic interaction between the two medicines. Bisoprolol does not affect tirzepatide's absorption, and tirzepatide does not alter bisoprolol blood levels. That said, both medicines influence heart rate, so starting them together — or adding Mounjaro to an established bisoprolol regimen — is something a prescriber should look at carefully before you begin. Mounjaro is a prescription-only medicine requiring a full clinical assessment; your prescriber will review your cardiovascular history, your current bisoprolol dose, and your overall picture before deciding whether treatment is suitable for you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you've had your annual review, your GP has noted your weight, and someone has mentioned tirzepatide as an option. You go home and search whether bisoprolol and Mounjaro can sit alongside each other. The short answer is yes, for most people, but it takes more than a quick internet search to make that call safely.
Bisoprolol is a beta-blocker, most often prescribed for heart failure, high blood pressure, or certain arrhythmias. It works by blocking adrenaline's effect on the heart, slowing the rate and reducing the force of each beat. Tirzepatide, the active ingredient in Mounjaro, is a dual GIP and GLP-1 receptor agonist that works on appetite and blood-sugar regulation. The two mechanisms are quite different, which is why no direct drug-drug interaction has been identified in the prescribing literature.
Where it gets worth thinking about is the indirect picture. Beta-blockers already keep resting heart rate on the lower side. Some people starting GLP-1 medicines notice a modest rise in resting pulse, particularly in the early weeks, a known physiological effect that is usually mild and temporary. In someone whose heart rate is already managed by bisoprolol, that small shift is unlikely to cause problems, but your prescriber will want to know your baseline before you begin. The full eligibility picture for Mounjaro covers more about what a prescriber looks at during a first assessment.
One practical note: the MHRA and NHS advise telling every member of your healthcare team, including your GP, that you are starting a GLP-1 medicine. If bisoprolol was prescribed by a cardiologist, it is worth letting that team know too. Clinicians don't always share the same records automatically, and the full picture matters here.
This is something a lot of people on bisoprolol don't think about until it's relevant. Significant weight loss, of the kind that Mounjaro can help produce over months of treatment, genuinely changes cardiovascular physiology. Blood pressure tends to fall. Resting heart rate can drop. The workload on the heart reduces.
For someone on bisoprolol, that's largely good news, the underlying reasons for being on the medicine may improve. But it also means the dose that was right at the start of treatment might not be the right dose six months later. If your pulse drops low, or you start feeling dizzy or unusually tired, that is worth raising with the GP who manages your bisoprolol, rather than adjusting anything yourself.
Mounjaro's licensed titration schedule starts at a low dose specifically to let your body adjust gradually. Weight loss is incremental, and the effects on blood pressure and heart rate play out over weeks and months, not overnight. Even so, anyone with a cardiac history benefits from their GP being in the loop from day one. The BMI criteria for Mounjaro set out the eligibility thresholds, though cardiovascular conditions like high blood pressure can themselves count as a weight-related comorbidity that affects your eligibility, your prescriber weighs all of this together.
According to the NHS tirzepatide patient information, people with a history of heart conditions should discuss their suitability with a clinician before beginning treatment. That isn't a reason to rule it out; it's a reason to do it properly. You can read that guidance directly on the NHS tirzepatide page.
Bisoprolol is one of several beta-blockers used in the UK. If you've seen information about taking Mounjaro with propranolol, you'll notice the questions are similar but not identical. Propranolol is non-selective, meaning it affects beta receptors in more places than bisoprolol does, and it's also metabolised differently. The principle of discussing all cardiac medicines with your prescriber applies to both, but the specific considerations vary. Never assume what applies to one beta-blocker applies identically to another.
A few other interactions come up regularly in this context. Mounjaro slows gastric emptying, which affects how quickly other oral medicines reach the gut for absorption. For most drugs, including bisoprolol, this effect is modest and clinically unlikely to be significant at Mounjaro's standard doses. For medicines with a narrow therapeutic window, however, it's worth flagging. If you're also taking supplements and wondering whether they fit into this picture, our page on whether NMN can be taken alongside Mounjaro is a useful reference for how that kind of question gets approached. If you're curious about other combinations, our prescribers field questions like this routinely, it's the sort of thing that gets looked at as part of a medication review before any prescription is issued.
It's also worth knowing that weight loss can indirectly affect other medicines you may take alongside bisoprolol. Statins, blood pressure medicines, and diabetes treatments can all need revisiting as your weight changes. Keeping your GP updated means those adjustments happen at the right time. For context on what the private treatment pathway looks like and what it costs, the Mounjaro pricing page covers the background honestly.
If you decide to explore Mounjaro through a private pharmacy, the process matters as much as the medicine. At nume, your consultation isn't processed by software. A GPhC-registered Independent Prescriber reads your answers personally, checks your medication list (including bisoprolol and anything else you take), and makes a clinical judgement the same day. If something in your history needs clarifying, they'll ask.
Part of that process includes identity and weight verification, and a check on your GP record where appropriate, the kind of step that catches contraindications that a questionnaire alone might miss. If your prescription is approved and you order before noon on a working day, your first pen ships the same day and arrives via DPD the next working day, in plain, unbranded packaging with a discreet label. Nothing on the box announces what's inside.
Our clinical team also notifies your GP in line with GPhC guidance, so your bisoprolol prescriber stays informed throughout. That loop matters, particularly for anyone on cardiac medicines where the clinical picture is likely to evolve as weight changes.
If you have further questions about how specific conditions or medicines affect your eligibility, the FAQs cover a broad range of scenarios. When you're ready, you can check your eligibility through a free consultation with our prescribers, no commitment, just an honest clinical assessment of whether Mounjaro is the right fit for you.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.